FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4292242419> ?p ?o ?g. }

• W4292242419 abstract "Chemotherapeutic treatment with conventional drug formulations pose numerous challenges, such as poor solubility, high cytotoxicity and serious off-target side effects, low bioavailability, and ultimately subtherapeutic tumoral concentration leading to poor therapeutic outcomes. In the field of Nanomedicine, advances in nanotechnology have been applied with great success to design and develop novel nanoparticle-based formulations for the treatment of various types of cancer. The approval of the first nanomedicine, Doxil® (liposomal doxorubicin) in 1995, paved the path for further development for various types of novel delivery platforms. Several different types of nanoparticles, especially organic (soft) nanoparticles (liposomes, polymeric micelles, and albumin-bound nanoparticles), have been developed and approved for several anticancer drugs. Nanoparticulate drug delivery platform have facilitated to overcome of these challenges and offered key advantages of improved bioavailability, higher intra-tumoral concentration of the drug, reduced toxicity, and improved efficacy. This review introduces various commonly used nanoparticulate systems in biomedical research and their pharmacokinetic (PK) attributes, then focuses on the various physicochemical and physiological factors affecting the in vivo disposition of chemotherapeutic agents encapsulated in nanoparticles in recent years. Further, it provides a review of the current landscape of soft nanoparticulate formulations for the two most widely investigated anticancer drugs, paclitaxel, and doxorubicin, that are either approved or under investigation. Formulation details, PK profiles, and therapeutic outcomes of these novel strategies have been discussed individually and in comparison, to traditional formulations. This article is categorized under: Nanotechnology Approaches to Biology > Cells at the Nanoscale Diagnostic Tools > In Vivo Nanodiagnostics and Imaging Therapeutic Approaches and Drug Discovery > Nanomedicine for Oncologic Disease." @default.
• W4292242419 created "2022-08-19" @default.
• W4292242419 creator A5000302734 @default.
• W4292242419 creator A5017620945 @default.
• W4292242419 creator A5023203109 @default.
• W4292242419 creator A5039146242 @default.
• W4292242419 creator A5040085266 @default.
• W4292242419 date "2022-08-18" @default.
• W4292242419 modified "2023-09-26" @default.
• W4292242419 title "Pharmacokinetic behaviors of soft nanoparticulate formulations of chemotherapeutics" @default.
• W4292242419 cites W1470598344 @default.
• W4292242419 cites W1874889006 @default.
• W4292242419 cites W1972979576 @default.
• W4292242419 cites W1984216302 @default.
• W4292242419 cites W1984424468 @default.
• W4292242419 cites W1994654668 @default.
• W4292242419 cites W2005296909 @default.
• W4292242419 cites W2015741364 @default.
• W4292242419 cites W2022040578 @default.
• W4292242419 cites W2027969748 @default.
• W4292242419 cites W2028694954 @default.
• W4292242419 cites W2030087487 @default.
• W4292242419 cites W2030184956 @default.
• W4292242419 cites W2036254354 @default.
• W4292242419 cites W2041915312 @default.
• W4292242419 cites W2055049428 @default.
• W4292242419 cites W2070898084 @default.
• W4292242419 cites W2078279342 @default.
• W4292242419 cites W2088566214 @default.
• W4292242419 cites W2089576694 @default.
• W4292242419 cites W2097748705 @default.
• W4292242419 cites W2100411451 @default.
• W4292242419 cites W2100508256 @default.
• W4292242419 cites W2102903528 @default.
• W4292242419 cites W2119703555 @default.
• W4292242419 cites W2120553873 @default.
• W4292242419 cites W2136447069 @default.
• W4292242419 cites W2138834684 @default.
• W4292242419 cites W2142504874 @default.
• W4292242419 cites W2143463421 @default.
• W4292242419 cites W2147462392 @default.
• W4292242419 cites W2149077650 @default.
• W4292242419 cites W2154747925 @default.
• W4292242419 cites W2157430581 @default.
• W4292242419 cites W2167144064 @default.
• W4292242419 cites W2169601017 @default.
• W4292242419 cites W2175000645 @default.
• W4292242419 cites W2175185830 @default.
• W4292242419 cites W2184694295 @default.
• W4292242419 cites W2189686237 @default.
• W4292242419 cites W2202510566 @default.
• W4292242419 cites W2219320085 @default.
• W4292242419 cites W2229915948 @default.
• W4292242419 cites W2257241327 @default.
• W4292242419 cites W2301135976 @default.
• W4292242419 cites W2316397280 @default.
• W4292242419 cites W2335360019 @default.
• W4292242419 cites W2344543596 @default.
• W4292242419 cites W2402357292 @default.
• W4292242419 cites W2407297656 @default.
• W4292242419 cites W2409885204 @default.
• W4292242419 cites W2464231245 @default.
• W4292242419 cites W2495773034 @default.
• W4292242419 cites W2594239688 @default.
• W4292242419 cites W2597191820 @default.
• W4292242419 cites W2597887107 @default.
• W4292242419 cites W2599276599 @default.
• W4292242419 cites W2625747098 @default.
• W4292242419 cites W2736992479 @default.
• W4292242419 cites W2758199728 @default.
• W4292242419 cites W2761496094 @default.
• W4292242419 cites W2762066258 @default.
• W4292242419 cites W2774011186 @default.
• W4292242419 cites W2783352565 @default.
• W4292242419 cites W2792549134 @default.
• W4292242419 cites W2801053964 @default.
• W4292242419 cites W2804357818 @default.
• W4292242419 cites W2810841038 @default.
• W4292242419 cites W2883399820 @default.
• W4292242419 cites W2890167612 @default.
• W4292242419 cites W2891041615 @default.
• W4292242419 cites W2893833733 @default.
• W4292242419 cites W2899607400 @default.
• W4292242419 cites W2902366943 @default.
• W4292242419 cites W2902612033 @default.
• W4292242419 cites W2905600615 @default.
• W4292242419 cites W2913363035 @default.
• W4292242419 cites W2928990695 @default.
• W4292242419 cites W2946205823 @default.
• W4292242419 cites W2949802189 @default.
• W4292242419 cites W2957984348 @default.
• W4292242419 cites W2964642102 @default.
• W4292242419 cites W2964749580 @default.
• W4292242419 cites W2966953072 @default.
• W4292242419 cites W2969959482 @default.
• W4292242419 cites W2976760128 @default.
• W4292242419 cites W2980030327 @default.
• W4292242419 cites W2982426301 @default.
• W4292242419 cites W2985892902 @default.
• W4292242419 cites W2988116293 @default.

• next